|
EP1855694B1
(en)
|
2005-02-09 |
2020-12-02 |
Sarepta Therapeutics, Inc. |
Antisense composition for treating muscle atrophy
|
|
US8236557B2
(en)
*
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
EP2524037B1
(en)
|
2010-01-12 |
2018-05-16 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
US9169492B2
(en)
|
2010-02-05 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
WO2012109570A1
(en)
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
WO2013075008A1
(en)
*
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
CN103405774A
(zh)
*
|
2012-10-24 |
2013-11-27 |
尹海芳 |
一种新型药物靶向运输辅助剂
|
|
US20140140969A1
(en)
*
|
2012-11-20 |
2014-05-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for muscular dystrophies
|
|
US9624282B2
(en)
*
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
ES2926774T3
(es)
|
2013-03-15 |
2022-10-28 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para vectores AAV de doble unión de glicano
|
|
WO2014143932A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
US10907176B2
(en)
|
2015-01-14 |
2021-02-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
JP6832280B2
(ja)
*
|
2015-01-16 |
2021-02-24 |
ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ |
新規のマイクロジストロフィンおよび使用の関連する方法
|
|
HK1248554A1
(zh)
|
2015-02-20 |
2018-10-19 |
Board Of Regents, The University Of Texas System |
作为疫苗和载体的减毒衣原体的方法和组合物
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
ES2865487T3
(es)
|
2015-09-28 |
2021-10-15 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para vectores virales que evaden los anticuerpos
|
|
EP3858993A1
(en)
|
2015-10-09 |
2021-08-04 |
Sarepta Therapeutics, Inc. |
Compositions and methods for treating duchenne muscular dystrophy and related disorders
|
|
KR102877920B1
(ko)
|
2015-11-16 |
2025-10-30 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
티틴-기반 근증 및 다른 티틴성병증의 치료를 위한 물질 및 방법
|
|
JP7406783B2
(ja)
|
2015-12-14 |
2023-12-28 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
|
|
ES2977730T3
(es)
|
2016-04-15 |
2024-08-29 |
Res Inst Nationwide Childrens Hospital |
Administración de microARN-29 y micro-distrofina por virus adenoasociado para tratar la distrofia muscular
|
|
LT3442600T
(lt)
|
2016-04-15 |
2024-05-27 |
Research Institute At Nationwide Children's Hospital |
Su adeno virusu susijusio viruso vektoriaus iš β-sarkoglikano ir mikro- rnr-29 pristatymas ir raumenų distrofijos gydymas
|
|
WO2017223128A1
(en)
*
|
2016-06-21 |
2017-12-28 |
The Curators Of The University Of Missouri |
Modified dystrophin proteins
|
|
CA2971303C
(en)
*
|
2016-06-21 |
2026-03-03 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
IL305149A
(en)
|
2016-07-26 |
2023-10-01 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
|
JP7165410B2
(ja)
|
2016-08-19 |
2022-11-04 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド |
組換え自己相補的アデノ随伴ウイルスを使用して疾患を治療するための方法及び組成物
|
|
KR20190088561A
(ko)
|
2016-12-07 |
2019-07-26 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
인터류킨-1 수용체 길항제(IL-1RA) cDNA
|
|
WO2018162748A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
NZ756587A
(en)
|
2017-03-15 |
2025-12-19 |
Univ North Carolina Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
|
EP3596112A2
(en)
|
2017-03-17 |
2020-01-22 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
KR102606810B1
(ko)
|
2017-05-05 |
2023-11-27 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
오토펄린을 발현시키기 위한 조성물 및 방법
|
|
MA50836A
(fr)
|
2017-10-18 |
2020-08-26 |
Res Inst Nationwide Childrens Hospital |
Administration par vecteur à virus adéno-associé de micro-dystrophine spécifique de muscles pour traiter la dystrophie musculaire
|
|
KR102777452B1
(ko)
|
2017-11-22 |
2025-03-10 |
아지오스 파마슈티컬스 아이엔씨. |
N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의결정 형태
|
|
AR114350A1
(es)
|
2018-01-31 |
2020-08-26 |
Res Institute At Nationwide ChildrenS Hospital |
Terapia genética para la distrofia muscular de cinturas del tipo 2c
|
|
EP3759218A4
(en)
|
2018-02-28 |
2021-12-08 |
The University of North Carolina at Chapel Hill |
PROCEDURES AND COMPOSITIONS FOR ANTIBODY ELIMINATING VIRUS VECTORS
|
|
EP3774852A1
(en)
|
2018-04-03 |
2021-02-17 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
MX2020010465A
(es)
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
AU2019247748A1
(en)
|
2018-04-03 |
2020-10-08 |
Ginkgo Bioworks, Inc. |
Antibody-evading virus vectors
|
|
US12460226B2
(en)
|
2018-04-16 |
2025-11-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating duchenne muscular dystrophy
|
|
CN112703016B
(zh)
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
TW202016314A
(zh)
|
2018-05-09 |
2020-05-01 |
美商拜奧馬林製藥公司 |
治療苯丙酮尿症之方法
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
MY208145A
(en)
*
|
2018-06-18 |
2025-04-18 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy
|
|
EP3810782A2
(en)
|
2018-06-22 |
2021-04-28 |
Asklepios Biopharmaceutical, Inc. |
Vectors for gene delivery that persist within cells
|
|
KR20210028162A
(ko)
|
2018-06-29 |
2021-03-11 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
지대근 이영양증 2a형을 치료하기 위한 재조합 아데노 연관 바이러스 생성물 및 방법
|
|
WO2020093018A1
(en)
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
CA3129422A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
AU2020229340A1
(en)
|
2019-02-26 |
2021-09-16 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of B-sarcoglycan and the treatment of muscular dystrophy
|
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
|
US12466864B2
(en)
|
2019-03-25 |
2025-11-11 |
Genethon |
Production of large-sized quasidystrophins using overlapping AAV vectors
|
|
EP4169535A1
(en)
|
2019-04-26 |
2023-04-26 |
The University of North Carolina at Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
AU2020284255A1
(en)
|
2019-05-30 |
2022-01-06 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
JP2022540819A
(ja)
*
|
2019-07-10 |
2022-09-20 |
ユニバーシティ オブ ワシントン |
非ウイルス性免疫標的化
|
|
RS65421B1
(sr)
|
2019-08-21 |
2024-05-31 |
Res Inst Nationwide Childrens Hospital |
Isporuka adeno-asociranog virusnog vektora alfa-sarkoglikana i lečenje mišićne distrofije
|
|
JP2022551739A
(ja)
|
2019-10-17 |
2022-12-13 |
ストライドバイオ，インコーポレイテッド |
ニーマン・ピック病ｃ型の治療のためのアデノ随伴ウイルスベクター
|
|
US12611436B2
(en)
|
2019-10-17 |
2026-04-28 |
Sarepta Therapeutics, Inc. |
AAV transfer cassette
|
|
KR20220130093A
(ko)
|
2019-10-30 |
2022-09-26 |
데시벨 테라퓨틱스, 인크. |
오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 조성물 및 방법
|
|
WO2021089736A1
(en)
|
2019-11-06 |
2021-05-14 |
Association Institut De Myologie |
Combined therapy for muscular diseases
|
|
TWI908746B
(zh)
*
|
2019-11-28 |
2025-12-21 |
美商銳進科斯生物股份有限公司 |
微小肌縮蛋白基因療法之構築體及其用途
|
|
CN115666658A
(zh)
|
2020-04-01 |
2023-01-31 |
佛罗里达州大学研究基金会 |
具有提高的治疗ush1b的安全性的双aav-myo7a载体
|
|
IL297753A
(en)
*
|
2020-04-29 |
2022-12-01 |
Bristol Myers Squibb Co |
Minimized dystrophins with spectrin fusion domains and uses thereof
|
|
AU2021328475A1
(en)
|
2020-08-19 |
2023-03-16 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus vectors for treatment of Rett syndrome
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
WO2022093769A1
(en)
|
2020-10-28 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
CN116490514A
(zh)
|
2020-10-28 |
2023-07-25 |
北卡罗来纳-查佩尔山大学 |
用于双重聚糖结合aav2.5载体的方法和组合物
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
EP4320139A1
(en)
|
2021-04-05 |
2024-02-14 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
WO2022221529A1
(en)
|
2021-04-16 |
2022-10-20 |
Asklepios Biopharmaceutical, Inc. |
Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
|
|
JP2024517143A
(ja)
*
|
2021-04-26 |
2024-04-19 |
リジェネックスバイオ インコーポレイテッド |
ジストロフィン異常症の治療のためのマイクロジストロフィン遺伝子療法投与
|
|
US20240390522A1
(en)
*
|
2021-09-28 |
2024-11-28 |
University Of Florida Research Foundation, Incorporated |
Gene therapy for duchenne muscular dystrophy
|
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN115960946B
(zh)
*
|
2021-10-09 |
2026-02-13 |
中国科学院分子植物科学卓越创新中心 |
调节植物镁离子吸收和转运的方法
|
|
EP4219726A1
(en)
|
2021-10-15 |
2023-08-02 |
Research Institute at Nationwide Children's Hospital |
Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy
|
|
CN119233831A
(zh)
*
|
2022-01-17 |
2024-12-31 |
迪纳柯公司 |
用于与肌营养不良蛋白有关的心肌病的基因疗法组合物和治疗
|
|
EP4215614A1
(en)
|
2022-01-24 |
2023-07-26 |
Dynacure |
Combination therapy for dystrophin-related diseases
|
|
TW202342759A
(zh)
|
2022-02-04 |
2023-11-01 |
美商史崔德生物公司 |
重組腺相關病毒載體及其使用方法
|
|
US20250288641A1
(en)
*
|
2022-04-27 |
2025-09-18 |
The Curators Of The University Of Missouri |
Micro-dystrophin for heart protection
|
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|
|
WO2024216244A2
(en)
|
2023-04-13 |
2024-10-17 |
Regenxbio Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2025017168A1
(en)
*
|
2023-07-19 |
2025-01-23 |
Genethon |
Novel optimized utrophin micro-genes
|